This NDC is on FDA's drug shortage list (posted Mar 23, 2018)
Reported reason: Delay in shipping of the drug
Product Information
KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.4980 per ML under NDC 63323016202. Its NADAC has been published 634 times since Nov 28, 2013.
FDA first approved this application on Jan 11, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323016202
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA075784FDA Approved
1/11/2002
TE Code
AP
On Market Since
10/18/2000
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 634 times since Nov 28, 2013, and over the history we have for it it has risen 21.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4980 per ML |
|---|---|
| All-time high | $1.5377 (Apr 15, 2015) |
| All-time low | $0.3997 (Feb 19, 2014) |
| 52-week high | $0.5738 |
| 52-week low | $0.4543 |
| Median price | $0.8975 |
| Average price | $0.8929 |
| Largest weekly change | +94.1% (Mar 18, 2015) |
| Weeks tracked | 634 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.4980 per ML (NDC 63323016202), effective Aug 19, 2026.
How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has risen 21.6%. It has been tracked across 634 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.3997 (Feb 19, 2014) to a high of $1.5377 (Apr 15, 2015), with a median of $0.8975 per ML.
Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 60 MG/2 ML VIAL?
KETOROLAC 60 MG/2 ML VIAL (NDC 63323016202) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is KETOROLAC 60 MG/2 ML VIAL in shortage?
Yes — NDC 63323016202 is currently listed in FDA's drug shortage database (posted Mar 23, 2018). Reported reason: Delay in shipping of the drug.